Post by icemandios on May 10, 2023 12:47:42 GMT
THE OFFERING
The Selling Stockholders identified in this prospectus are offering on a resale basis a total of 734,515 shares of Common Stock issuable upon the exercise of the Warrants.
Common Stock to be offered by the Selling Stockholders Up to 734,515 shares of Common Stock
Common Stock outstanding prior to this offering
1,139,024 shares of Common Stock as of December 31, 2022
Common Stock to be outstanding after this offering 1,873,539 1 shares of Common Stock
Use of proceeds: We will not receive any proceeds from the sale of the shares of Common Stock by the Selling Stockholders, except for the Warrant exercise price paid for the Common Stock offered hereby and issuable upon the exercise of the Warrants. See “ Use of Proceeds ” on page 6 of this prospectus.
Risk factors: You should read the “ Risk Factors ” section beginning on page 5 of this prospectus for a discussion of factors to consider carefully before deciding to invest in shares of our securities.
Nasdaq Capital Market symbol: Our common stock is listed on The Nasdaq Capital Market under the symbol “PHIO.” We do not intend to apply for listing of the Warrants on any securities exchange or nationally recognized trading system.
1 The number of shares of Common Stock to be outstanding after this offering is based on 1,139,024 shares of Common Stock outstanding as of December 31, 2022 and excludes as of such date:
· 353,983 shares of Common Stock issued to the Selling Stockholders on April 20, 2023 in connection with the Registered Direct Offering;
· 141 shares of Common Stock issuable upon the exercise of stock options outstanding as of December 31, 2022, having a weighted average exercise price of $19,761.12 per share;
· 47,328 shares of Common Stock issuable upon the vesting of restricted stock units outstanding as of December 31, 2022;
· 545,401 shares of Common Stock issuable upon the exercise of warrants outstanding as of December 31, 2022, having a weighted average exercise price of $36.33 per share;
· 43,807 shares of Common Stock reserved for future issuance under our 2020 Long-Term Incentive Plan as of December 31, 2022; and
· 660 shares of Common Stock reserved for future issuance under our Employee Stock Purchase Plan as of December 31, 2022.
The Selling Stockholders identified in this prospectus are offering on a resale basis a total of 734,515 shares of Common Stock issuable upon the exercise of the Warrants.
Common Stock to be offered by the Selling Stockholders Up to 734,515 shares of Common Stock
Common Stock outstanding prior to this offering
1,139,024 shares of Common Stock as of December 31, 2022
Common Stock to be outstanding after this offering 1,873,539 1 shares of Common Stock
Use of proceeds: We will not receive any proceeds from the sale of the shares of Common Stock by the Selling Stockholders, except for the Warrant exercise price paid for the Common Stock offered hereby and issuable upon the exercise of the Warrants. See “ Use of Proceeds ” on page 6 of this prospectus.
Risk factors: You should read the “ Risk Factors ” section beginning on page 5 of this prospectus for a discussion of factors to consider carefully before deciding to invest in shares of our securities.
Nasdaq Capital Market symbol: Our common stock is listed on The Nasdaq Capital Market under the symbol “PHIO.” We do not intend to apply for listing of the Warrants on any securities exchange or nationally recognized trading system.
1 The number of shares of Common Stock to be outstanding after this offering is based on 1,139,024 shares of Common Stock outstanding as of December 31, 2022 and excludes as of such date:
· 353,983 shares of Common Stock issued to the Selling Stockholders on April 20, 2023 in connection with the Registered Direct Offering;
· 141 shares of Common Stock issuable upon the exercise of stock options outstanding as of December 31, 2022, having a weighted average exercise price of $19,761.12 per share;
· 47,328 shares of Common Stock issuable upon the vesting of restricted stock units outstanding as of December 31, 2022;
· 545,401 shares of Common Stock issuable upon the exercise of warrants outstanding as of December 31, 2022, having a weighted average exercise price of $36.33 per share;
· 43,807 shares of Common Stock reserved for future issuance under our 2020 Long-Term Incentive Plan as of December 31, 2022; and
· 660 shares of Common Stock reserved for future issuance under our Employee Stock Purchase Plan as of December 31, 2022.